Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Hims & Hers Health Inc shares valued at $275,114 were sold by Okupe Oluyemi on Jan 20 ’26. At $30.34 per share, Okupe Oluyemi sold 9,067 shares. The insider’s holdings dropped to 91,617 shares worth approximately $2.65 million following the completion of this transaction.
Also, Oluyemi Okupe purchased 27,204 shares, netting a total of over 828,906 in proceeds.
Before that, Okupe Oluyemi had sold 9,070 shares from its account. In a trade valued at $306,453, the Chief Financial Officer traded Hims & Hers Health Inc shares for $33.79 each. Upon closing the transaction, the insider’s holdings decreased to 9,070 shares, worth approximately $2.65 million.
As published in their initiating research note from Evercore ISI on January 12, 2026, Hims & Hers Health Inc [HIMS] has been an In-line and the price target has been revised to $33. Analysts at Barclays started covering the stock with ‘”an Overweight”‘ outlook in a report released in early December. As of October 21, 2025, KeyBanc Capital Markets has initiated its “Sector weight” rating for HIMS. Earlier on June 23, 2025, Needham downgraded its rating. Their new recommendation was “a Hold” for HIMS stock which previously was a “a Buy”.
Analyzing HIMS Stock Performance
On last trading session, Hims & Hers Health Inc [NYSE: HIMS] plunged -5.19% to $28.89. The stock’s lowest price that day was $27.96, but it reached a high of $30.64 in the same session. During the last five days, there has been a drop of approximately -10.28%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 3.73%.
Is Hims & Hers Health Inc subject to short interest?
Stocks of Hims & Hers Health Inc saw a sharp steep in short interest on 2025-12-31 dropping by -0.23 million shares to 67.1 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 67.33 million shares. A decline of -0.34% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.4 of the overall float, the days-to-cover ratio (short ratio) decline to 5.4.
Which companies own the most shares of Hims & Hers Health Inc (HIMS)?
In terms of Hims & Hers Health Inc share price expectations, FactSet research, analysts set an average price target of 40 in the next 12 months, up nearly 31.28% from the previous closing price of $30.47. Analysts anticipate Hims & Hers Health Inc stock to reach 59 by 2026, with the lowest price target being 29. In spite of this, 13 analysts ranked Hims & Hers Health Inc stock as Buy at the end of 2026. On June 04, 2025, Needham assigned a price target of “a Buy” to the stock and reiterated coverage with a $65.
